Publications by authors named "Guojun Yang"

Are you Guojun Yang?   Register this Author

A New Medium for Improving Spinosad Production by Saccharopolyspora spinosa.
Jundishapur J Microbiol 2016 Jun 30;9(6):e16765. Epub 2016 May 30.
Hubei Nature's Favor Biotechnology, Hanchuan, Hubei, People's Republic of China; College of Plant Science and Technology, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China; Key laboratory of Synthetic Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, Shanghai, People's Republic of China.

Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.
Proc Natl Acad Sci U S A 2015 Sep 8;112(38):E5290-9. Epub 2015 Sep 8.
Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030

Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Vaccine 2014 Dec 2;32(51):6934-6940. Epub 2014 Nov 2.
Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States; Department of Veterinary Sciences, The University of Texas M.D. Anderson Cancer Center, Bastrop, TX, United States. Electronic address:

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant.
Vaccines (Basel) 2014 Oct;2(4):686-706
Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA ; Department of Veterinary Sciences, The University of Texas M.D. Anderson Cancer Center, Bastrop, TX 78602, USA.

Combined IL-21 and low-dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model.
J Transl Med 2006 Jun 13;4:24. Epub 2006 Jun 13.
Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.

Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV.
PLoS One 2013 3;8(7):e67574. Epub 2013 Jul 3.
Department of Internal Medicine, Division of Infectious Diseases, Translational Immunovirology Program, Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America.


Sublingual vaccination induces mucosal and systemic adaptive immunity for protection against lung tumor challenge.
PLoS One 2014 5;9(3):e90001. Epub 2014 Mar 5.
Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America; Immunology Graduate Program, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, United States of America.

OF